| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |